nodes	percent_of_prediction	percent_of_DWPC	metapath
Diethylstilbestrol—ABCG2—Leflunomide—systemic scleroderma	0.161	0.176	CbGbCtD
Diethylstilbestrol—AOX1—Methotrexate—systemic scleroderma	0.146	0.159	CbGbCtD
Diethylstilbestrol—CYP2C8—Mometasone—systemic scleroderma	0.133	0.145	CbGbCtD
Diethylstilbestrol—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0992	0.109	CbGbCtD
Diethylstilbestrol—ABCB1—Lisinopril—systemic scleroderma	0.0607	0.0664	CbGbCtD
Diethylstilbestrol—CYP2C9—Leflunomide—systemic scleroderma	0.0597	0.0653	CbGbCtD
Diethylstilbestrol—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0528	0.0578	CbGbCtD
Diethylstilbestrol—ABCB1—Captopril—systemic scleroderma	0.0454	0.0497	CbGbCtD
Diethylstilbestrol—ABCG2—Methotrexate—systemic scleroderma	0.0398	0.0435	CbGbCtD
Diethylstilbestrol—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0358	0.0391	CbGbCtD
Diethylstilbestrol—ABCB1—Prednisone—systemic scleroderma	0.0286	0.0313	CbGbCtD
Diethylstilbestrol—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0214	0.0234	CbGbCtD
Diethylstilbestrol—CYP2C9—cardial valve—systemic scleroderma	0.0179	0.264	CbGeAlD
Diethylstilbestrol—CYP3A4—Prednisone—systemic scleroderma	0.0171	0.0187	CbGbCtD
Diethylstilbestrol—ABCB1—Methotrexate—systemic scleroderma	0.0143	0.0157	CbGbCtD
Diethylstilbestrol—ESRRG—tendon—systemic scleroderma	0.00432	0.0636	CbGeAlD
Diethylstilbestrol—ESRRG—lung—systemic scleroderma	0.00379	0.0559	CbGeAlD
Diethylstilbestrol—ESR1—blood vessel—systemic scleroderma	0.00287	0.0422	CbGeAlD
Diethylstilbestrol—TTR—connective tissue—systemic scleroderma	0.0027	0.0397	CbGeAlD
Diethylstilbestrol—ESR2—connective tissue—systemic scleroderma	0.00215	0.0316	CbGeAlD
Diethylstilbestrol—ESR2—smooth muscle tissue—systemic scleroderma	0.00196	0.0289	CbGeAlD
Diethylstilbestrol—TTR—digestive system—systemic scleroderma	0.00195	0.0287	CbGeAlD
Diethylstilbestrol—COMT—smooth muscle tissue—systemic scleroderma	0.00187	0.0275	CbGeAlD
Diethylstilbestrol—COMT—skin of body—systemic scleroderma	0.00185	0.0272	CbGeAlD
Diethylstilbestrol—ESR1—FOXM1 transcription factor network—CENPB—systemic scleroderma	0.00174	0.0953	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—connective tissue—systemic scleroderma	0.00169	0.0249	CbGeAlD
Diethylstilbestrol—TTR—lung—systemic scleroderma	0.00163	0.024	CbGeAlD
Diethylstilbestrol—ESR2—digestive system—systemic scleroderma	0.00155	0.0228	CbGeAlD
Diethylstilbestrol—AOX1—digestive system—systemic scleroderma	0.00149	0.022	CbGeAlD
Diethylstilbestrol—COMT—digestive system—systemic scleroderma	0.00148	0.0217	CbGeAlD
Diethylstilbestrol—ESR1—connective tissue—systemic scleroderma	0.00147	0.0216	CbGeAlD
Diethylstilbestrol—AOX1—tendon—systemic scleroderma	0.00142	0.0209	CbGeAlD
Diethylstilbestrol—COMT—tendon—systemic scleroderma	0.00141	0.0207	CbGeAlD
Diethylstilbestrol—ESR1—smooth muscle tissue—systemic scleroderma	0.00134	0.0198	CbGeAlD
Diethylstilbestrol—CYP2A6—lung—systemic scleroderma	0.0013	0.0192	CbGeAlD
Diethylstilbestrol—ESR2—lung—systemic scleroderma	0.00129	0.0191	CbGeAlD
Diethylstilbestrol—AOX1—lung—systemic scleroderma	0.00125	0.0183	CbGeAlD
Diethylstilbestrol—COMT—lung—systemic scleroderma	0.00123	0.0182	CbGeAlD
Diethylstilbestrol—ABCB1—blood vessel—systemic scleroderma	0.00113	0.0167	CbGeAlD
Diethylstilbestrol—ESR1—digestive system—systemic scleroderma	0.00106	0.0156	CbGeAlD
Diethylstilbestrol—AOX1—Effects of Nitric Oxide—NOS3—systemic scleroderma	0.00103	0.0563	CbGpPWpGaD
Diethylstilbestrol—TTR—Retinoid metabolism and transport—HSPG2—systemic scleroderma	0.000993	0.0543	CbGpPWpGaD
Diethylstilbestrol—TTR—Non-integrin membrane-ECM interactions—HSPG2—systemic scleroderma	0.000974	0.0533	CbGpPWpGaD
Diethylstilbestrol—ESR1—lung—systemic scleroderma	0.000886	0.0131	CbGeAlD
Diethylstilbestrol—CYP2C9—digestive system—systemic scleroderma	0.000777	0.0114	CbGeAlD
Diethylstilbestrol—CYP2E1—digestive system—systemic scleroderma	0.000736	0.0108	CbGeAlD
Diethylstilbestrol—TTR—Amyloids—TGFBI—systemic scleroderma	0.00073	0.0399	CbGpPWpGaD
Diethylstilbestrol—ABCG2—lung—systemic scleroderma	0.00071	0.0105	CbGeAlD
Diethylstilbestrol—CYP2E1—tendon—systemic scleroderma	0.0007	0.0103	CbGeAlD
Diethylstilbestrol—ESRRG—Generic Transcription Pathway—SMAD7—systemic scleroderma	0.000696	0.0381	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—lung—systemic scleroderma	0.000615	0.00905	CbGeAlD
Diethylstilbestrol—CYP3A4—digestive system—systemic scleroderma	0.000592	0.00872	CbGeAlD
Diethylstilbestrol—TTR—Amyloids—HSPG2—systemic scleroderma	0.000582	0.0318	CbGpPWpGaD
Diethylstilbestrol—TTR—Diseases associated with visual transduction—HSPG2—systemic scleroderma	0.000507	0.0277	CbGpPWpGaD
Diethylstilbestrol—ESR1—FOXM1 transcription factor network—CENPA—systemic scleroderma	0.00046	0.0251	CbGpPWpGaD
Diethylstilbestrol—ABCB1—digestive system—systemic scleroderma	0.000419	0.00617	CbGeAlD
Diethylstilbestrol—ESRRG—Generic Transcription Pathway—CTGF—systemic scleroderma	0.000385	0.021	CbGpPWpGaD
Diethylstilbestrol—ABCB1—lung—systemic scleroderma	0.00035	0.00515	CbGeAlD
Diethylstilbestrol—ESR2—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000348	0.019	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—systemic scleroderma	0.000336	0.0184	CbGpPWpGaD
Diethylstilbestrol—ESRRG—Gene Expression—SMAD7—systemic scleroderma	0.000335	0.0183	CbGpPWpGaD
Diethylstilbestrol—TTR—Extracellular matrix organization—FBN1—systemic scleroderma	0.00032	0.0175	CbGpPWpGaD
Diethylstilbestrol—ESRRG—Gene Expression—TNFSF13—systemic scleroderma	0.000312	0.017	CbGpPWpGaD
Diethylstilbestrol—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD7—systemic scleroderma	0.000311	0.017	CbGpPWpGaD
Diethylstilbestrol—ESR2—Plasma membrane estrogen receptor signaling—MMP2—systemic scleroderma	0.000273	0.0149	CbGpPWpGaD
Diethylstilbestrol—ESR2—Plasma membrane estrogen receptor signaling—NOS3—systemic scleroderma	0.000256	0.014	CbGpPWpGaD
Diethylstilbestrol—ESR1—AP-1 transcription factor network—COL1A2—systemic scleroderma	0.000255	0.0139	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000228	0.0125	CbGpPWpGaD
Diethylstilbestrol—ESR1—Regulation of nuclear SMAD2/3 signaling—COL1A2—systemic scleroderma	0.000227	0.0124	CbGpPWpGaD
Diethylstilbestrol—TTR—Extracellular matrix organization—COL1A2—systemic scleroderma	0.000224	0.0122	CbGpPWpGaD
Diethylstilbestrol—TTR—Extracellular matrix organization—HSPG2—systemic scleroderma	0.000224	0.0122	CbGpPWpGaD
Diethylstilbestrol—TTR—Non-integrin membrane-ECM interactions—TGFB1—systemic scleroderma	0.000213	0.0116	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	0.000211	0.0115	CbGpPWpGaD
Diethylstilbestrol—ESR2—Plasma membrane estrogen receptor signaling—MMP9—systemic scleroderma	0.000205	0.0112	CbGpPWpGaD
Diethylstilbestrol—TTR—Extracellular matrix organization—ITGAM—systemic scleroderma	0.000203	0.0111	CbGpPWpGaD
Diethylstilbestrol—ESR1—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	0.000189	0.0103	CbGpPWpGaD
Diethylstilbestrol—ESRRG—Gene Expression—CTGF—systemic scleroderma	0.000185	0.0101	CbGpPWpGaD
Diethylstilbestrol—ESR1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000176	0.0096	CbGpPWpGaD
Diethylstilbestrol—ESR2—Generic Transcription Pathway—SMAD7—systemic scleroderma	0.000154	0.00843	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000143	0.00784	CbGpPWpGaD
Diethylstilbestrol—ABCG2—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000142	0.00774	CbGpPWpGaD
Diethylstilbestrol—ESR1—AP-1 transcription factor network—EDN1—systemic scleroderma	0.000138	0.00755	CbGpPWpGaD
Diethylstilbestrol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—systemic scleroderma	0.000138	0.00753	CbGpPWpGaD
Diethylstilbestrol—ESR1—FOXM1 transcription factor network—MMP2—systemic scleroderma	0.000135	0.00739	CbGpPWpGaD
Diethylstilbestrol—ESR1—Plasma membrane estrogen receptor signaling—NOS3—systemic scleroderma	0.000129	0.00705	CbGpPWpGaD
Diethylstilbestrol—ESR1—AP-1 transcription factor network—MMP1—systemic scleroderma	0.000116	0.00634	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Allograft Rejection—IL13—systemic scleroderma	0.000105	0.00573	CbGpPWpGaD
Diethylstilbestrol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—systemic scleroderma	0.000104	0.00566	CbGpPWpGaD
Diethylstilbestrol—ESR1—ATF-2 transcription factor network—MMP2—systemic scleroderma	0.000103	0.00563	CbGpPWpGaD
Diethylstilbestrol—TTR—Extracellular matrix organization—MMP1—systemic scleroderma	0.000102	0.00557	CbGpPWpGaD
Diethylstilbestrol—ESR1—AP-1 transcription factor network—CCL2—systemic scleroderma	9.43e-05	0.00516	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	9.29e-05	0.00508	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—SMAD7—systemic scleroderma	8.83e-05	0.00483	CbGpPWpGaD
Diethylstilbestrol—ESR2—Generic Transcription Pathway—CTGF—systemic scleroderma	8.53e-05	0.00466	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	8.43e-05	0.00461	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—TGFBI—systemic scleroderma	8.08e-05	0.00442	CbGpPWpGaD
Diethylstilbestrol—ESR1—Leptin signaling pathway—NOS3—systemic scleroderma	7.96e-05	0.00435	CbGpPWpGaD
Diethylstilbestrol—TTR—Extracellular matrix organization—MMP2—systemic scleroderma	7.88e-05	0.00431	CbGpPWpGaD
Diethylstilbestrol—ESR1—Generic Transcription Pathway—SMAD7—systemic scleroderma	7.78e-05	0.00425	CbGpPWpGaD
Diethylstilbestrol—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	7.65e-05	0.00418	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—SMAD7—systemic scleroderma	7.51e-05	0.00411	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	7.47e-05	0.00409	CbGpPWpGaD
Diethylstilbestrol—ESR2—Gene Expression—SMAD7—systemic scleroderma	7.42e-05	0.00406	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	7.01e-05	0.00383	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	6.94e-05	0.00379	CbGpPWpGaD
Diethylstilbestrol—ESR2—Gene Expression—TNFSF13—systemic scleroderma	6.9e-05	0.00377	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—TGFBI—systemic scleroderma	6.87e-05	0.00375	CbGpPWpGaD
Diethylstilbestrol—ESR1—Leptin signaling pathway—IL1B—systemic scleroderma	6.77e-05	0.0037	CbGpPWpGaD
Diethylstilbestrol—ESR1—AP-1 transcription factor network—MMP9—systemic scleroderma	6.75e-05	0.00369	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	6.59e-05	0.0036	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	6.55e-05	0.00358	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—HSPG2—systemic scleroderma	6.44e-05	0.00352	CbGpPWpGaD
Diethylstilbestrol—ESR1—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	6.27e-05	0.00343	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—CSK—systemic scleroderma	6.22e-05	0.0034	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—SMAD7—systemic scleroderma	6.18e-05	0.00338	CbGpPWpGaD
Diethylstilbestrol—TTR—Extracellular matrix organization—MMP9—systemic scleroderma	5.93e-05	0.00324	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—CD247—systemic scleroderma	5.85e-05	0.0032	CbGpPWpGaD
Diethylstilbestrol—ESR1—Regulation of Telomerase—TGFB1—systemic scleroderma	5.69e-05	0.00311	CbGpPWpGaD
Diethylstilbestrol—ESR1—AP-1 transcription factor network—TGFB1—systemic scleroderma	5.56e-05	0.00304	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—HSPG2—systemic scleroderma	5.48e-05	0.00299	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	5.33e-05	0.00291	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—CSK—systemic scleroderma	5.29e-05	0.00289	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—CD247—systemic scleroderma	4.97e-05	0.00272	CbGpPWpGaD
Diethylstilbestrol—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	4.94e-05	0.0027	CbGpPWpGaD
Diethylstilbestrol—TTR—Extracellular matrix organization—TGFB1—systemic scleroderma	4.88e-05	0.00267	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—RHOB—systemic scleroderma	4.78e-05	0.00262	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—HSPG2—systemic scleroderma	4.59e-05	0.00251	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—HSPG2—systemic scleroderma	4.51e-05	0.00247	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—CSK—systemic scleroderma	4.36e-05	0.00238	CbGpPWpGaD
Diethylstilbestrol—ESR1—Generic Transcription Pathway—CTGF—systemic scleroderma	4.3e-05	0.00235	CbGpPWpGaD
Diethylstilbestrol—ESR2—Gene Expression—CTGF—systemic scleroderma	4.1e-05	0.00224	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—HSPG2—systemic scleroderma	4.09e-05	0.00224	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.04e-05	0.00221	CbGpPWpGaD
Diethylstilbestrol—ESR1—Gene Expression—SMAD7—systemic scleroderma	3.74e-05	0.00205	CbGpPWpGaD
Diethylstilbestrol—ESR1—Gene Expression—TNFSF13—systemic scleroderma	3.48e-05	0.0019	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—CTGF—systemic scleroderma	3.48e-05	0.0019	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	3.44e-05	0.00188	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—CTGF—systemic scleroderma	3.1e-05	0.00169	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.9e-05	0.00158	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—NRF2 pathway—TGFB1—systemic scleroderma	2.75e-05	0.0015	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	2.67e-05	0.00146	CbGpPWpGaD
Diethylstilbestrol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	2.49e-05	0.00136	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—EDN1—systemic scleroderma	2.44e-05	0.00134	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—SMAD7—systemic scleroderma	2.43e-05	0.00133	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—HSPG2—systemic scleroderma	2.37e-05	0.0013	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.36e-05	0.00129	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.19e-05	0.0012	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—NOS3—systemic scleroderma	2.13e-05	0.00116	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—HSPG2—systemic scleroderma	2.08e-05	0.00114	CbGpPWpGaD
Diethylstilbestrol—ESR1—Gene Expression—CTGF—systemic scleroderma	2.07e-05	0.00113	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—HSPG2—systemic scleroderma	1.89e-05	0.00103	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—RHOB—systemic scleroderma	1.88e-05	0.00103	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—NOS3—systemic scleroderma	1.81e-05	0.000988	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—CTGF—systemic scleroderma	1.8e-05	0.000983	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.79e-05	0.000977	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—HSPG2—systemic scleroderma	1.78e-05	0.000971	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—CSK—systemic scleroderma	1.72e-05	0.000938	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—CCL2—systemic scleroderma	1.67e-05	0.000913	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—CTGF—systemic scleroderma	1.58e-05	0.000861	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—NOS3—systemic scleroderma	1.51e-05	0.000827	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—HSPG2—systemic scleroderma	1.49e-05	0.000816	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—NOS3—systemic scleroderma	1.49e-05	0.000814	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—CTGF—systemic scleroderma	1.43e-05	0.000782	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—TGFB1—systemic scleroderma	1.41e-05	0.000768	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—NOS3—systemic scleroderma	1.35e-05	0.000737	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.32e-05	0.000721	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—HSPG2—systemic scleroderma	1.29e-05	0.000705	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—TGFB1—systemic scleroderma	1.19e-05	0.000653	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—MMP9—systemic scleroderma	1.19e-05	0.000653	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—CTGF—systemic scleroderma	1.13e-05	0.000618	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—HSPG2—systemic scleroderma	1.12e-05	0.000614	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—HSPG2—systemic scleroderma	1.05e-05	0.000574	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—TGFB1—systemic scleroderma	9.84e-06	0.000538	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—CTGF—systemic scleroderma	9.77e-06	0.000534	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—EDN1—systemic scleroderma	9.61e-06	0.000526	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—CTGF—systemic scleroderma	8.52e-06	0.000466	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—CTGF—systemic scleroderma	7.96e-06	0.000435	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—NOS3—systemic scleroderma	7.83e-06	0.000428	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—HSPG2—systemic scleroderma	6.92e-06	0.000378	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—NOS3—systemic scleroderma	6.86e-06	0.000375	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—CCL2—systemic scleroderma	6.57e-06	0.000359	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—NOS3—systemic scleroderma	6.23e-06	0.000341	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—NOS3—systemic scleroderma	5.86e-06	0.00032	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—CTGF—systemic scleroderma	5.25e-06	0.000287	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—NOS3—systemic scleroderma	4.92e-06	0.000269	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—MMP9—systemic scleroderma	4.7e-06	0.000257	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—NOS3—systemic scleroderma	4.25e-06	0.000233	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—TGFB1—systemic scleroderma	3.87e-06	0.000212	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—NOS3—systemic scleroderma	3.71e-06	0.000203	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—NOS3—systemic scleroderma	3.46e-06	0.000189	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—NOS3—systemic scleroderma	2.28e-06	0.000125	CbGpPWpGaD
